George E. Laramore, MD, PhDDr. Laramore specializes in treating patients for salivary gland tumors, head and neck cancer, sarcoma of the soft tissue and bone, and genitourinary tumors particularly prostate cancer at UW Medical Center and SCCA Proton Therapy.
Patient Care Philosophy:
High tech medicine can be adapted to the individual patient's needs. I enjoy using the latest technological innovations in radiation oncology to design and carry out the optimal treatment for each patient.
Dr. Laramore's Resume
- Professor, Radiation Oncology Department, University of Washington School of Medicine
- Radiation Oncologist, University of Washington Medical Center
- Radiation Oncologist, SCCA Proton Therapy, A ProCure Center
Salivary gland tumors; head and neck cancer; sarcoma of soft tissue and bone; prostate cancer; and treatment with fast neutron radiotherapy, proton therapy, and intensity-modulated radiation therapy (IMRT)
Education And Training
- Medical Education: University of Miami School of Medicine, 1976
- Residency: Radiation Oncology Radiation Oncology, University of Washington School of Medicine, 1977-1978
- Fellowship: American Cancer Society Clinical Fellow, 1979-1980
- Pre/Post-doctoral in physics: National Science Foundation, 1965-1970
- Dr. Laramore was recognized as a 2012 "Top Doctor" in Seattle Magazine's 2012 annual survey.
- Dr. Laramore is board certified and is a fellow.
- Radiation Therapy vs. Androgen Deprivation
- Radiation w/wo Temozolomide for Low-Grade Gliomas (RTOG-1072)
- Whole Breast Irradiation with Hypofractionation versus standard Whole Breast Irradiation (RTOG 1005)
- Postoperative Radiation Therapy +/- Cetuximab for Head and Neck Cancer (RTOG 0920)
- Radiation Therapy + Chemotherapy for Stage T1 Bladder Cancer (UW 7684)
- Radiation Therapy With or Without Temozolomide for Anaplastic Glioma (RTOG 0834)
- Bevacizumab w/wo Radiation Therapy for Recurrent Glioblastoma (RTOG-1205)
- Registry Study for Proton Therapy Outcomes